Bank of America Corp DE Buys 36,123 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Bank of America Corp DE lifted its stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 79.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,427 shares of the company’s stock after purchasing an additional 36,123 shares during the quarter. Bank of America Corp DE owned 0.10% of Stereotaxis worth $186,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of STXS. Two Sigma Securities LLC purchased a new stake in Stereotaxis during the 4th quarter valued at $54,000. Wells Fargo & Company MN boosted its position in shares of Stereotaxis by 53.7% during the fourth quarter. Wells Fargo & Company MN now owns 26,915 shares of the company’s stock valued at $61,000 after buying an additional 9,403 shares during the last quarter. Hsbc Holdings PLC boosted its position in shares of Stereotaxis by 102.6% during the fourth quarter. Hsbc Holdings PLC now owns 42,581 shares of the company’s stock valued at $97,000 after buying an additional 21,563 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Stereotaxis in the 4th quarter worth about $101,000. Finally, Envestnet Asset Management Inc. raised its position in Stereotaxis by 23.5% in the 4th quarter. Envestnet Asset Management Inc. now owns 61,075 shares of the company’s stock worth $139,000 after buying an additional 11,622 shares during the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Stock Performance

Stereotaxis stock opened at $2.11 on Monday. Stereotaxis, Inc. has a one year low of $1.54 and a one year high of $2.72. The stock has a fifty day moving average of $2.03 and a 200 day moving average of $2.08. The stock has a market cap of $178.78 million, a PE ratio of -7.54 and a beta of 1.54.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.